BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 8 | -38.5% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 13 | -38.1% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 21 | -4.5% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 22 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 22 | -24.1% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 29 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 29 | -31.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 42 | +2.4% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 41 | -14.6% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 48 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |